eBook: Formulation of Dry Powder Inhaler - 33
2:1 BEV:CP. Figure S8: Predicted v. experimental water
content for the 9 simul-spray formulations. Table
S1: Headspace sampler and instrument parameters
for GC headspace analysis of residual solvent.
Author Contributions: Conceptualization, K.B.S.;
experiments, A.M.P. and K.B.S.; writing-original
draft preparation, K.B.S. and A.M.P.; writing-review
and editing, D.T.V.; supervision, D.T.V. All authors
have read and agreed to the published version of
the manuscript.
Funding: This research received no external funding.
Data Availability Statement: Not applicable.
Acknowledgments
Thank you to John España of Lonza for custom
manufacturing the simul-spray prototype atomizer
wand.
Conflicts of Interest: K.B.S., A.M.P. and D.T.V. are employees
of Lonza. The Lonza had no role in the design
of the study; in the collection, analyses, or interpretation
of data; in the writing of the manuscript, or
in the decision to publish the results.
References
1. Hill, N.S.; Preston, I.R.; Roberts, K.E. Inhaled Therapies for
Pulmonary Hypertension. Respir. Care 2015, 60, 794-802.
[CrossRef] [PubMed]
2. Hickey, A.J. Emerging trends in inhaled drug delivery. Adv. Drug
Deliv. Rev. 2020, 157, 63-70. [CrossRef] [PubMed]
3. Goel, A.; Sahni, J.; Ali, J.; Baboota, S. Exploring targeted pulmonary
delivery for treatment of lung cancer. Int. J. Pharm. Investig. 2013,
3, 8-14. [CrossRef]
4. Atkins, P.J. Dry powder inhalers: An overview. Respir. Care 2005,
50, 1304. [PubMed]
5. Drugs@FDA. 2021. Available online: https://www.accessdata.fda.
gov/scripts/cder/daf/ (accessed on 5 February 2022).
6. Chaurasiya, B.; Zhao, Y.-Y. Dry Powder for Pulmonary Delivery: A
Comprehensive Review. Pharmaceutics 2020, 13, 31. [CrossRef]
[PubMed]
7.
Sharma, A.; Khamar, D.; Cullen, S.; Hayden, A.; Hughes, H.
Innovative Drying Technologies for Biopharmaceuticals. Int. J.
Pharm. 2021, 609, 121115. [CrossRef] [PubMed]
8. Eedara, B.B.; Alabsi, W.; Encinas-Basurto, D.; Polt, R.; Mansour,
H.M. Spray-Dried Inhalable Powder Formulations of Therapeutic
Proteins and Peptides. AAPS PharmSciTech 2021, 22, 185.
[CrossRef]
9. Chang, R.Y.K.; Chow, M.Y.; Khanal, D.; Chen, D.; Chan, H.-K. Dry
powder pharmaceutical biologics for inhalation therapy. Adv.
Drug Deliv. Rev. 2021, 172, 64-79. [CrossRef]
10. Vehring, R. Pharmaceutical Particle Engineering via Spray Drying.
Pharm. Res. 2007, 25, 999-1022. [CrossRef]
11. Baumann, J.M.; Adam, M.S.; Wood, J.D. Engineering Advances in
Spray Drying for Pharmaceuticals. Annu. Rev. Chem. Biomol. Eng.
2021, 12, 217-240. [CrossRef]
12. Snyder, H.E.; Vosberg, M.J.; Varga, C.M. Spray Drying Methods and
Related Compositions; Novartis: Basel, Switzerland, 2013.
13. Geller, D.E.; Weers, J.; Heuerding, S. Development of an Inhaled
Dry-Powder Formulation of Tobramycin Using PulmoSphere™
Technology. J. Aerosol Med. Pulm. Drug Deliv. 2011, 24, 175-182.
[CrossRef] [PubMed]
14. Pilcer, G.; Rosière, R.; Traina, K.; Sebti, T.; Vanderbist, F.; Amighi, K.
New Co-Spray-Dried Tobramycin Nanoparticles-Clarithromycin
Inhaled Powder Systems for Lung Infection Therapy in Cystic
Fibrosis Patients. J. Pharm. Sci. 2013, 102, 1836-1846. [CrossRef]
[PubMed]
15. Malamatari, M.; Charisi, A.; Malamataris, S.; Kachrimanis, K.;
Nikolakakis, I. Spray Drying for the Preparation of NanoparticleBased
Drug Formulations as Dry Powders for Inhalation.
Processes 2020, 8, 788. [CrossRef]
16. McCormack, P.L.; Keam, S.J. Bevacizumab. Drugs 2008, 68,
487-506. [CrossRef]
33
https://www.accessdata.fda
eBook: Formulation of Dry Powder Inhaler
Table of Contents for the Digital Edition of eBook: Formulation of Dry Powder Inhaler
eBook: Formulation of Dry Powder Inhaler - 1
eBook: Formulation of Dry Powder Inhaler - 2
eBook: Formulation of Dry Powder Inhaler - 3
eBook: Formulation of Dry Powder Inhaler - 4
eBook: Formulation of Dry Powder Inhaler - 5
eBook: Formulation of Dry Powder Inhaler - 6
eBook: Formulation of Dry Powder Inhaler - 7
eBook: Formulation of Dry Powder Inhaler - 8
eBook: Formulation of Dry Powder Inhaler - 9
eBook: Formulation of Dry Powder Inhaler - 10
eBook: Formulation of Dry Powder Inhaler - 11
eBook: Formulation of Dry Powder Inhaler - 12
eBook: Formulation of Dry Powder Inhaler - 13
eBook: Formulation of Dry Powder Inhaler - 14
eBook: Formulation of Dry Powder Inhaler - 15
eBook: Formulation of Dry Powder Inhaler - 16
eBook: Formulation of Dry Powder Inhaler - 17
eBook: Formulation of Dry Powder Inhaler - 18
eBook: Formulation of Dry Powder Inhaler - 19
eBook: Formulation of Dry Powder Inhaler - 20
eBook: Formulation of Dry Powder Inhaler - 21
eBook: Formulation of Dry Powder Inhaler - 22
eBook: Formulation of Dry Powder Inhaler - 23
eBook: Formulation of Dry Powder Inhaler - 24
eBook: Formulation of Dry Powder Inhaler - 25
eBook: Formulation of Dry Powder Inhaler - 26
eBook: Formulation of Dry Powder Inhaler - 27
eBook: Formulation of Dry Powder Inhaler - 28
eBook: Formulation of Dry Powder Inhaler - 29
eBook: Formulation of Dry Powder Inhaler - 30
eBook: Formulation of Dry Powder Inhaler - 31
eBook: Formulation of Dry Powder Inhaler - 32
eBook: Formulation of Dry Powder Inhaler - 33
eBook: Formulation of Dry Powder Inhaler - 34
eBook: Formulation of Dry Powder Inhaler - 35
eBook: Formulation of Dry Powder Inhaler - 36
eBook: Formulation of Dry Powder Inhaler - 37
eBook: Formulation of Dry Powder Inhaler - 38
eBook: Formulation of Dry Powder Inhaler - 39
eBook: Formulation of Dry Powder Inhaler - 40
eBook: Formulation of Dry Powder Inhaler - 41
eBook: Formulation of Dry Powder Inhaler - 42
eBook: Formulation of Dry Powder Inhaler - 43
eBook: Formulation of Dry Powder Inhaler - 44
eBook: Formulation of Dry Powder Inhaler - 45
eBook: Formulation of Dry Powder Inhaler - 46
eBook: Formulation of Dry Powder Inhaler - 47
https://www.nxtbookmedia.com